Reducing Opioid Overdose Mortality: Role of Community-Administered Naloxone

Speakers:

Vennus Ballen, MD, MPH

Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene

Lara Maldjian, MPH

Acting Naloxone Program Coordinator, Special Assistant to the Assistant Commissioner, New York City Department of Health and Mental Hygiene

Summary of Session Goals:

The goal of this session is to educate attendees on New York City’s opioid epidemic, naloxone distribution, and naloxone use.

Learning Objectives:

1. Understand the epidemiology of drug overdose in the United States and New York City
2. Learn about New York City’s responses to the opioid overdose epidemic
3. Learn about the use and effectiveness of naloxone in community settings

A Live Webcast Sponsored by:

Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667)

Date:

Thursday June 23, 2016 12:00 PM to 1:30 PM EST

Slideset-

Reducing Opioid Overdose Mortality: Role of Community-Administered Naloxone

Recent Webcasts